These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Leukoregulin, a direct-acting anticancer immunological hormone that is distinct from lymphotoxin and interferon. Ransom JH, Evans CH, McCabe RP, Pomato N, Heinbaugh JA, Chin M, Hanna MG. Cancer Res; 1985 Feb 15; 45(2):851-62. PubMed ID: 3881174 [Abstract] [Full Text] [Related]
8. Tumor targets stimulate IL-2 activated killer cells to produce interferon-gamma and tumor necrosis factor. Chong AS, Scuderi P, Grimes WJ, Hersh EM. J Immunol; 1989 Mar 15; 142(6):2133-9. PubMed ID: 2493506 [Abstract] [Full Text] [Related]
9. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF). Wright SC, Bonavida B. J Immunol; 1983 Jun 15; 130(6):2965-8. PubMed ID: 6189909 [Abstract] [Full Text] [Related]
10. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF). Wright SC, Bonavida B. J Immunol; 1983 Jun 15; 130(6):2960-4. PubMed ID: 6189908 [Abstract] [Full Text] [Related]
11. Human interleukin 1 is a cytocidal factor for several tumor cell lines. Onozaki K, Matsushima K, Aggarwal BB, Oppenheim JJ. J Immunol; 1985 Dec 15; 135(6):3962-8. PubMed ID: 2415593 [Abstract] [Full Text] [Related]
12. IFN-gamma treatment of K562 cells inhibits natural killer cell triggering and decreases the susceptibility to lysis by cytoplasmic granules from large granular lymphocytes. Grönberg A, Ferm MT, Ng J, Reynolds CW, Ortaldo JR. J Immunol; 1988 Jun 15; 140(12):4397-402. PubMed ID: 3131433 [Abstract] [Full Text] [Related]
13. Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon. Degliantoni G, Murphy M, Kobayashi M, Francis MK, Perussia B, Trinchieri G. J Exp Med; 1985 Nov 01; 162(5):1512-30. PubMed ID: 3932579 [Abstract] [Full Text] [Related]
16. Role of NK cell cytotoxic factor against fresh human tumors. Uchida A, Fukata H. Nat Immun; 1993 Nov 01; 12(4-5):267-78. PubMed ID: 8257831 [Abstract] [Full Text] [Related]